Perbedaan Organon Pharma Indonesia Tbk. dan Tunas Baru Lampung Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Tunas Baru Lampung Tbk. diperdagangkan di Rp625 (kapitalisasi pasar 3,8 T, volume 24 jam 1,07 jt). Perbedaan utamanya: Tunas Baru Lampung Tbk. jauh lebih besar — sekitar 36,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TBLA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 3,8 T |
Volume | — | 1,07 jt |
Lot | — | 10,69 rb |
Perputaran | — | 664,27 jt |
Harga Rata-rata | — | 621,51 |
Nilai Transaksi | — | 664,27 jt |
Harga Ekuilibrium Indikatif | — | 625 |
Volume Ekuilibrium Indikatif | — | 142 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Tunas Baru Lampung Tbk (the Company) was established by virtue of Notarial Deed No. 23 dated December 22, 1973 of Halim Kurniawan, S.H., public notary in Teluk Betung. PT. Tunas Baru Lampung is a member of Sungai Budi Group which was founded in 1947 and is a pioneer in Indonesia`s agricultural industry.
Selengkapnya di halaman TBLA →